Reckitt Benckiser (RBGLY) could spin off its declining pharmaceuticals operations, saying that the idea is "emerging as a strong option." However, selling the business or even keeping it are still possible.
The division's net sales dropped 15% in Q1 to £170M.
Total net revenues declined 6% to £2.37B.
Shares are +0.3% in London. (PR)